Paper528263
Terminology in the description of drug-radiation interactions.
Steel GG. Int J Radiat Oncol Biol Phys, 1979. Cited by 174 papers, by iCite.
Cite this record
ConductScience Library. Terminology in the description of drug-radiation interactions. Papers, record 528263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/528263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms, Experimental | Major topic |
| Radiotherapy | Major topic |
| Terminology as Topic | Major topic |
| Animals | |
| Cell Survival | |
| Cells, Cultured | |
| Cricetinae | |
| Dose-Response Relationship, Radiation | |
| Mice | |
| Radiation Injuries, Experimental | |
| Radiation-Protective Agents | |
| Radiation-Sensitizing Agents |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 174 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41117982 | Peptide receptor radionuclide therapy alone or in combination with temozolomide plus/minus capecitabine in [18F]FDG-positive metastatic neuroendocrine tumors. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/41117982 | PubMed |
| 40583736 | Significance of Platinum-Based Chemotherapy With Programmed Death-1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective Study. | Thorac Cancer | 2025 | https://conductscience.org/library/papers/40583736 | PubMed |
| 36760380 | Palliative extracranial radiotherapy in patients receiving immunotherapy for non-small cell lung cancer: a narrative review. | Transl Cancer Res | 2023 | https://conductscience.org/library/papers/36760380 | PubMed |
| 35976726 | The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation. | Radiat Res | 2022 | https://conductscience.org/library/papers/35976726 | PubMed |
| 35716328 | Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer. | Curr Treat Options Oncol | 2022 | https://conductscience.org/library/papers/35716328 | PubMed |
| 32914000 | Applying Precision Oncology Principles in Radiation Oncology. | JCO Precis Oncol | 2018 | https://conductscience.org/library/papers/32914000 | PubMed |
| 32731592 | DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32731592 | PubMed |
| 32668592 | Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32668592 | PubMed |
| 32335187 | The Promise of Combining Radiation Therapy With Immunotherapy. | Int J Radiat Oncol Biol Phys | 2020 | https://conductscience.org/library/papers/32335187 | PubMed |
| 27043632 | Radioresistance of Brain Tumors. | Cancers (Basel) | 2016 | https://conductscience.org/library/papers/27043632 | PubMed |
| 26205191 | EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection. | Pharmacol Ther | 2015 | https://conductscience.org/library/papers/26205191 | PubMed |
| 25113770 | Interaction of radiation therapy with molecular targeted agents. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/25113770 | PubMed |
| 24944704 | Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells. | Oncol Lett | 2014 | https://conductscience.org/library/papers/24944704 | PubMed |
| 23393324 | Fenbendazole as a potential anticancer drug. | Anticancer Res | 2013 | https://conductscience.org/library/papers/23393324 | PubMed |
| 22862779 | Preliminary studies with a new hypoxia-selective cytotoxin, KS119W, in vitro and in vivo. | Radiat Res | 2012 | https://conductscience.org/library/papers/22862779 | PubMed |
| 22111842 | Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors. | Int J Radiat Biol | 2012 | https://conductscience.org/library/papers/22111842 | PubMed |
| 21140241 | Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer. | Med Oncol | 2012 | https://conductscience.org/library/papers/21140241 | PubMed |
| 19884901 | Liver metastases from colorectal cancer: radioembolization with systemic therapy. | Nat Rev Clin Oncol | 2009 | https://conductscience.org/library/papers/19884901 | PubMed |
| 15642164 | Letrozole sensitizes breast cancer cells to ionizing radiation. | Breast Cancer Res | 2005 | https://conductscience.org/library/papers/15642164 | PubMed |
| 11714450 | Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin. | Jpn J Cancer Res | 2001 | https://conductscience.org/library/papers/11714450 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/528263
GET https://conductscience.org/api/papers/v1/528263/cited_by?page=2